2009 annual financial data

Rigel Pharmaceuticals 2009 Net margin

Rigel Pharmaceuticals 2009 net margin with verified reported values.

Direct answer

Net margin was -14,872.93%.

Operating income was -112,037,000 USD and net income was -111,547,000 USD.
Operating cash flow was -102,779,000 USD.

Get free Rigel Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
750,000 USD
Operating income
-112,037,000 USD
Net income
-111,547,000 USD
Operating cash flow
-102,779,000 USD